Stockscreener 앱 받기
4.12
1.44%
-0.06
Abcellera Biologics Inc 주식(ABCL)의 최신 뉴스
Is AbCellera (ABCL) Quietly Recasting Its Platform As A Menopause-Focused Drug Developer? - simplywall.st
Aug Reactions: What is the implied volatility of Sonida Senior Living IncMarket Movers & Weekly Hot Stock Watchlists - baoquankhu1.vn
Citizens Financial Group Inc. RI Acquires Shares of 261,890 AbCellera Biologics Inc. $ABCL - MarketBeat
AbCellera Biologics Pivots to Internal Pipeline at JPMorgan, Teases Key Milestones for 2026 - Yahoo Finance
AbCellera Biologics Inc Doses First Patients in Phase 2 Trial for ABCL635 - TradingView — Track All Markets
AbCellera Biologics (NASDAQ:ABCL) Shares Down 5.6%Should You Sell? - MarketBeat
AbCellera begins phase 2 trial of non-hormonal menopause treatment By Investing.com - Investing.com Nigeria
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause - BioSpace
AbCellera begins phase 2 trial of non-hormonal menopause treatment - Investing.com
AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL6 - PharmiWeb.com
AbCellera (ABCL) Advances Clinical Trial for Menopause Treatment - GuruFocus
AbCellera Biologics (NASDAQ:ABCL) Shares Gap Up on Analyst Upgrade - MarketBeat
Bear Alert: Is AbCellera Biologics Inc stock forming a triangle patternJuly 2025 Drop Watch & Smart Allocation Stock Tips - baoquankhu1.vn
Why AbCellera Biologics Inc. stock could rally in 2025Growth vs. Value Investing & Budget Friendly Trading Alerts - bollywoodhelpline.com
AbCellera Biologics (NASDAQ:ABCL) Rating Increased to Hold at Wall Street Zen - MarketBeat
Will AbCellera Biologics Inc. stock return to pre crisis levels2025 Pullback Review & Weekly Watchlist of Top Performers - Улправда
Can AbCellera Biologics Inc. stock maintain operating marginsJuly 2025 Macro Moves & Safe Capital Growth Plans - Улправда
How AbCellera Biologics Inc. stock performs in weak economyJuly 2025 WrapUp & Safe Capital Growth Plans - Улправда
Can AbCellera Biologics Inc. stock hit analyst price targetsMarket Correction Analysis & Maximize Returns With Insights - Улправда
AbCellera (ABCL) Loses Chief Commercial Officer to Viking Therap - GuruFocus
AbCellera Biologics (NASDAQ:ABCL) Trading Up 9.2%Still a Buy? - MarketBeat
AbCellera settles patent litigation with Bruker over microfluidic device tech - MSN
AbCellera Biologics (NASDAQ:ABCL) Cut to Sell at Wall Street Zen - MarketBeat
Is AbCellera Biologics Inc a good long term investmentMid Cap Growth Trends & These 3 Stocks Could Change Your Portfolio - earlytimes.in
MACD Cross Could Confirm Trend in Sancode Technologies LimitedEmerging Market Stocks & Unlock Patterns Humans Can’t See - earlytimes.in
Update Recap: How AbCellera Biologics Inc stock performs in weak economyExit Point & Real-Time Volume Analysis Alerts - moha.gov.vn
AbCellera Biologics Inc. (NASDAQ:ABCL) Given Average Recommendation of "Hold" by Analysts - MarketBeat
AbCellera Biologics (NASDAQ:ABCL) Upgraded at Wall Street Zen - MarketBeat
We're Not Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn - Yahoo Finance
AbCellera: Losing Its Undeserved Premium (NASDAQ:ABCL) - Seeking Alpha
AbCellera Appoints Dr. Stephen Quake to Board - MSN
Why AbCellera Biologics Inc. stock is in analyst buy zoneMarket Activity Report & High Accuracy Investment Entry Signals - Улправда
Can AbCellera Biologics Inc. stock beat analyst upgrades2025 Trading Volume Trends & Verified Stock Trade Ideas - Улправда
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? - MSN
AbCellera Biologics (STU:8QQ) EV-to-OCF : -6.77 (As of Dec. 22, 2025) - GuruFocus
AbCellera Gets $36M In Cell Research Patent Settlement - Law360
Buyout Rumor: How AbCellera Biologics Inc. stock performs in weak economyCEO Change & Weekly High Potential Alerts - DonanımHaber
Published on: 2025-12-19 14:45:34 - Улправда
AbCellera settles patent dispute with Bruker for $36 million upfront By Investing.com - Investing.com India
a2025-12x18brukerlitigat.htm - SEC.gov
AbCellera Secures Global Settlement and Patent License Deal - TipRanks
AbCellera Biologics Inc Settles Patent Litigation with Bruker - TradingView — Track All Markets
AbCellera stock jumps after settlement with Bruker in patent dispute By Investing.com - Investing.com South Africa
AbCellera stock jumps after settlement with Bruker in patent dispute - Investing.com
AbCellera Biologics (NASDAQ:ABCL) Trading 6.7% HigherHere's What Happened - MarketBeat
AbCellera and Bruker Reach Global Settlement of Patent Litigation - PharmiWeb.com
4.73%
0.92%
자본화:
|
볼륨(24시간):